Table 2.
Summary of chelators for the different radioactive isotopes and published labelling conditions (reaction temperature and incubation time).
| Isotope | Chelator | Labelling Conditions | Reference |
|---|---|---|---|
| [64Cu] | CB-TE2A a | 95 °C, 1 h | [113] |
| CB-TE2P | RT | [80] | |
| DOTA b | RT, 15 min | [114] | |
| NOTA c | RT, 45 min | [115] | |
| PCB-TE2A | RT | [75] | |
| TETA d | RT, 45 min | [74] | |
| Sarcophagine-based chelators | RT, within min | [75,82] | |
| [68Ga] | AAZTA e | RT, 10 min | [116] |
| DFO f | RT, 5 min | [116] | |
| DOTA b | 95 °C, 5 min | [116] | |
| DTPA g | RT, 10 min | [117] | |
| HBED-CC h | 80–100 °C, 5–20 min | [85] | |
| NODAGA i | RT, 10 min | [86] | |
| NOTA c | RT, 10 min | [118] | |
| TRAPj/NOPO k | 95–100 °C, 5 min; RT or 95 °C, 5 min | [87,89] | |
| [89Zr] | DFO f | RT, 30 min | [119] |
| DOTA b | 95 °C, 60 min | [97] | |
| FSC l | RT, 90 min | [120] | |
| [90Y] | 3p-C-NETA-NCS m | RT, 60 min | [106] |
| CHX-A’’-DTPA n | 37–75 °C, 30–60 min | [82] | |
| DOTA b | 80 °C, 20 min | [121] | |
| [177Lu] | 3p-C-NETA-NCS m | RT, 60 min | [106] |
| AAZTA-5 | RT, 10 min | [104] | |
| DOTA b | 80 °C, 20 min | [121] | |
| H4octapa o | RT, 15 min | [105] | |
| [224Ac] | DOTA b | 95 °C, 5 min | [109] |
| H2macropa p | RT, within several min | [112] | |
| HEHA q | 37 °C, 30 min | [122] |
a 4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane, b 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, c 1,4,7-triazacyclononane-1,4,7-triacetic acid, d 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid, e 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)]amino-6-methylperhydro-1,4-diazepine, f desferrioxamine B, g diethylenetriamine pentaacetic acid, h N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N′-diacetic acid, i 1,4,7-triazacyclononane,1-gluteric acid-4,7-acetic acid, j 1,4,7-triazacyclononane phosphinic acid, k 1,4,7-triazacyclononane-1,4-bis[methylene(hydroxymethyl)phosphinic acid]-7-[methylene(2-carboxyethyl) phosphinic acid], l fusarinine C, m {4-[2-(Bis-carboxy-methylamino)-5-(4-isothiocyanatophenyl) pentyl]-7-carboxymethyl[1,4,7] triazonan-1-yl}acetic acid, n 2-(p-isothiocyanatobenzyl)-cyclohexyldiethylenetriamine pentaacetic acid, o N,N′-bis(6-carboxy-2-pyridylmethyl)-ethylenediamine-N,N′-diacetic acid), p N,N’-bis[(6-carboxy-2-pyridil)methyl]-4,13-diaza-18-crown-6, q 1,4,7,10,13,16-hexaazacyclohexadecane-N,N′,N″,N‴,N′‴,N″‴-hexaacetic acid.